Top Abstract Purchase Related
Home
>
Node
>
Subnode

Gepirone in anxiety: a pilot study

Csanalosi, I.; Schweizer, E.; Case, W.G.; Rickels, K.

Journal of Clinical Psychopharmacology 7(1): 31-33

1987

ISSN/ISBN: 0271-0749
PMID: 2880873
Document Number: 296087
Ten patients suffering from generalized anxiety disorder were treated, after a single-blind placebo washout week, with the nonbenzodiazepine anxiolytic gepirone in a 6-week open label trial. Mean Hamilton Anxiety scores improved from 24.8 to 7.1 (p less than 0.01). Other physician- and patient-rated scales showed comparable improvement on a mean maximal dose of 41 mg of gepirone. The medication appeared to be nonsedating and well tolerated. The anxiolytic effect of the medication was very marked in several cases, and gepirone appears to have promise as an anxiolytic agent.

Document emailed within 1 workday
Secure & encrypted payments

Houck, C. 1998: An open-label pilot study of fluvoxamine for mixed anxiety-depression Psychopharmacology Bulletin 34(2): 225-227
Dowson, C.; Laing, R.; Barraclough, R.; Town, I.; Mulder, R.; Norris, K.; Drennan, C. 2001: The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study New Zealand Medical Journal 114(1141): 447-449
Diamond, S.; Leeds, M.F. 1977: Prevention of visual anxiety and proficiency problems in the senior air transport pilot Aviation Space and Environmental Medicine 48(9): 877-881
Bystritsky, A.; Kerwin, L.; Feusner, J.D.; Vapnik, T. 2008: A pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorder Psychopharmacology Bulletin 41(1): 46-51
Harto, N.E.; Branconnier, R.J.; Spera, K.F.; Dessain, E.C. 1988: Clinical profile of gepirone, a nonbenzodiazepine anxiolytic Psychopharmacology Bulletin 24(1): 154-160
Riemann, D. 1996: Anxiety disorders. Diagnosis and therapy in family practice. 1: Anxiety reactions--psychiatric disorders and anxiety--anxiety disorders Fortschritte der Medizin 114(33): 457-459
Moxnes, P.; Kann, F. 1979: The book "Anxiety and Organization": if we don't have management anxiety we suffer from systems anxiety Sygeplejersken 79(43): 12-14
McGrath, P.J.; Stewart, J.W.; Quitkin, F.M.; Wager, S.; Jenkins, S.W.; Archibald, D.G.; Stringfellow, J.C.; Robinson, D.S. 1994: Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement Journal of Clinical Psychopharmacology 14(5): 347-352
James, I.M. 1984: Practical aspects of the use of beta-blockers in anxiety states: situational anxiety Postgraduate Medical Journal 60(Suppl 2): 19-25
Hallstrom, C. 1984: Practical aspects of the use of beta-blockers in anxiety stress: morbid anxiety Postgraduate Medical Journal 60(Suppl 2): 26-28
Motak, E. 1987: The DSM IIi classification of anxiety disorders in the light of psychological models of anxiety Psychiatria Polska 21(6): 533-539
Ak, S.ç; Kılıç, C. 2017: Does Gender Affect the Relationship Between Anxiety Sensitivity and Social Anxiety? Turk Psikiyatri Dergisi 28(4): 240-245
Chevalier, A.; Bonenfant, S.; Picot, M.C.; Chastang, J.F.; Luce, D. 1996: Occupational factors of anxiety and depressive disorders in the French National Electricity and Gas Company. The Anxiety-Depression Group Journal of Occupational and Environmental Medicine 38(11): 1098-1107
Jalbout, N.; Karam, A.N.; Karam, E.; Feghaly, C.; Khalaf, H. 1994: Premedication with Midazolam (Dormicum) compared with Promethazine, Droperidol and placebo in relieving anxiety using Beck's anxiety inventory Le Journal Medical Libanais. Lebanese Medical Journal 42(2): 69-73
Videbech, M.; Carlsson, P.S.; Jensen, N.Christian.; Videbech, P. 2003: Measuring of preoperative anxiety by three self-reporting scales: State Trait Anxiety Inventory, Symptoms CheckList 92 and visual analogue scale Ugeskrift for Laeger 165(6): 569-574
Landén, M. 2001: Does smoking cause anxiety or does anxiety make us smoke? Lakartidningen 98(15): 1806
Troner, M.B.; Hemstreet, G.P. 1981: Cyclophosphamide, doxorubicin, and cisplatin (CAP) in the treatment of urothelial malignancy: a pilot study of the Southeastern Cancer Study Group Cancer Treatment Reports 65(1-2): 29-32
Levin, M.; Pandya, K.J.; Khandekar, J.D.; Horton, J.; Glick, J.H.; Bennett, J.M.; Muggia, F.M.; Falkson, G. 1984: Phase Ii study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 68(12): 1511-1512
Rosenthal, S.; Harris, D.T.; Horton, J.; Glick, J.H. 1980: Phase II study of maytansine in patients with advanced lymphomas: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 64(10-11): 1115-1117
Peter, K.; Jauch, M.; Bauer, U. 1995: Study of psychopathologic-biorhythm aspects of alcoholic patients in the withdrawal phase--initial results of a pilot study Wiener Medizinische Wochenschrift 145(17-18): 454-455